Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Moderna reicht Zulassungsantrag für seinen neu angepassten COVID-19-Impfstoff bei der Europäischen Arzneimittelagentur ein: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
Moderna reicht Zulassungsantrag für seinen neu angepassten COVID-19-Impfstoff bei der Europäischen Arzneimittelagentur ein

Die Einreichung folgt auf die Empfehlung der Regulierungsbehörden und öffentlichen Gesundheitseinrichtungen auf internationaler Ebene hinsichtlich der Entwicklung von monovalenten

Tesla: Can Downgrades Make Sense After A 170% Rally?: https://www.marketbeat.com/logos/articles/med_20230630104736_tesla-can-downgrades-make-sense-after-a-170-rally.jpg
Tesla: Can Downgrades Make Sense After A 170% Rally?

Sometimes the stock market can really make you scratch your head. As investors, we’re used to being always told to follow a trend, buy into a good thing, don’t catch the falling knife. This is why

Tesla: Can Downgrades Make Sense After A 170% Rally?: https://www.marketbeat.com/logos/articles/med_20230630104736_tesla-can-downgrades-make-sense-after-a-170-rally.jpg
Tesla: Can Downgrades Make Sense After A 170% Rally?

Sometimes the stock market can really make you scratch your head. As investors, we’re used to being always told to follow a trend, buy into a good thing, don’t catch the falling knife. This is why

Rally Gains Momentum On Soft PCE Data: https://www.marketbeat.com/logos/articles/med_20230630085513_chart-spx-6302023.png
Rally Gains Momentum On Soft PCE Data

The S&P 500 (NYSE: SPY) extended its summer rally after softer-than-expected PCE price data. The data is the latest in a string of good news that will help lift the market into mid-summer. The

Rally Gains Momentum On Soft PCE Data: https://www.marketbeat.com/logos/articles/med_20230630085513_chart-spx-6302023.png
Rally Gains Momentum On Soft PCE Data

The S&P 500 (NYSE: SPY) extended its summer rally after softer-than-expected PCE price data. The data is the latest in a string of good news that will help lift the market into mid-summer. The

Bank of America, JPMorgan, Goldman Sachs Set For Dividend Growth?: https://www.marketbeat.com/logos/articles/med_20230630085238_bank-of-america-jpmorgan-goldman-sachs-set-for-div.jpg
Bank of America, JPMorgan, Goldman Sachs Set For Dividend Growth?: https://www.marketbeat.com/logos/articles/med_20230630085238_bank-of-america-jpmorgan-goldman-sachs-set-for-div.jpg
SMART Global Holdings Momentum, Room To Move Higher?: https://www.marketbeat.com/logos/articles/med_20230630084902_smart-global-holdings-momentum-room-to-move-higher.jpg
SMART Global Holdings Momentum, Room To Move Higher?

SMART Global Holdings (NASDAQ: SGH) is part of the semiconductor family, a sector that has taken on the spotlight during the past few weeks; the attention to the space was drawn after NVIDIA

SMART Global Holdings Momentum, Room To Move Higher?: https://www.marketbeat.com/logos/articles/med_20230630084902_smart-global-holdings-momentum-room-to-move-higher.jpg
SMART Global Holdings Momentum, Room To Move Higher?

SMART Global Holdings (NASDAQ: SGH) is part of the semiconductor family, a sector that has taken on the spotlight during the past few weeks; the attention to the space was drawn after NVIDIA

SMART Global Holdings Momentum, Room To Move Higher?: https://www.marketbeat.com/logos/articles/med_20230630084902_smart-global-holdings-momentum-room-to-move-higher.jpg
SMART Global Holdings Momentum, Room To Move Higher?

SMART Global Holdings (NASDAQ: SGH) is part of the semiconductor family, a sector that has taken on the spotlight during the past few weeks; the attention to the space was drawn after NVIDIA

Freeport-McMoRan: Analysts Bullish Ahead Of Growth Copper's Spurt: https://www.marketbeat.com/logos/articles/med_20230630083217_freeport-mcmoran-analysts-bullish-ahead-of-growth.jpg
Freeport-McMoRan: Analysts Bullish Ahead Of Growth Copper's Spurt

When you think of the metal most crucial to the rapidly growing movement toward decarbonization, lithium might pop into your mind, as its use in batteries has been widely touted. 

But copper is

The Nike Rebound Is Over; Buying Opportunity Ahead: https://www.marketbeat.com/logos/articles/med_20230630075927_chart-nke-6302023.png
The Nike Rebound Is Over; Buying Opportunity Ahead

Nike (NYSE: NKE) proved again that it can Just Do It when operating in an ever-changing business environment. The Q3 results and guidance prove the company’s resiliency but also give evidence of

The Nike Rebound Is Over; Buying Opportunity Ahead: https://www.marketbeat.com/logos/articles/med_20230630075927_chart-nke-6302023.png
The Nike Rebound Is Over; Buying Opportunity Ahead

Nike (NYSE: NKE) proved again that it can Just Do It when operating in an ever-changing business environment. The Q3 results and guidance prove the company’s resiliency but also give evidence of

Verve Therapeutics Gains 20.74% In June as Ark Funds Invest: https://www.marketbeat.com/logos/articles/med_20230629144751_verve-therapeutics-gains-20.jpg
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest

Small-cap biotech Verve Therapeutics Inc. (NASDAQ: VERV) is up 20.74% in June, with some of that gain due to Cathie Wood’s Ark funds adding shares. 

Verve, which was founded in 2018 and went

Verve Therapeutics Gains 20.74% In June as Ark Funds Invest: https://www.marketbeat.com/logos/articles/med_20230629144751_verve-therapeutics-gains-20.jpg
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest

Small-cap biotech Verve Therapeutics Inc. (NASDAQ: VERV) is up 20.74% in June, with some of that gain due to Cathie Wood’s Ark funds adding shares. 

Verve, which was founded in 2018 and went

Verve Therapeutics Gains 20.74% In June as Ark Funds Invest: https://www.marketbeat.com/logos/articles/med_20230629144751_verve-therapeutics-gains-20.jpg
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest

Small-cap biotech Verve Therapeutics Inc. (NASDAQ: VERV) is up 20.74% in June, with some of that gain due to Cathie Wood’s Ark funds adding shares. 

Verve, which was founded in 2018 and went

Moderna: Declining Performance And Relative Weakness: https://www.marketbeat.com/logos/articles/med_20230629122911_screenshot-2023-06-29-121344.jpg
Moderna: Declining Performance And Relative Weakness

Moderna (NASDAQ: MRNA) was the top-performing stock in the S&P 500 not too long ago when the company joined the index in mid-2021. At its peak in 2021, the company's value soared to $187 billion

Is it Time To Ring The Register On Paychex?: https://www.marketbeat.com/logos/articles/med_20230629110600_chart-payx-6292023.png
Is it Time To Ring The Register On Paychex?

Paychex (NASDAQ: PAYX) shares are up more than 140% from the 2020 lows, but it may be time to ring the register. The Q4 results and outlook are good enough but failed to spark a rally in the

Is it Time To Ring The Register On Paychex?: https://www.marketbeat.com/logos/articles/med_20230629110600_chart-payx-6292023.png
Is it Time To Ring The Register On Paychex?

Paychex (NASDAQ: PAYX) shares are up more than 140% from the 2020 lows, but it may be time to ring the register. The Q4 results and outlook are good enough but failed to spark a rally in the

Is it Time To Ring The Register On Paychex?: https://www.marketbeat.com/logos/articles/med_20230629110600_chart-payx-6292023.png
Is it Time To Ring The Register On Paychex?

Paychex (NASDAQ: PAYX) shares are up more than 140% from the 2020 lows, but it may be time to ring the register. The Q4 results and outlook are good enough but failed to spark a rally in the

Micron Technology: A Reversal Is Imminent: https://www.marketbeat.com/logos/articles/med_20230629090827_copy-1-of-chart-mu-6292023.png
Micron Technology: A Reversal Is Imminent

Micron Technologies (NASDAQ: MU) has been suffering through an inventory correction that has yet to run its course, but a reversal in share prices is imminent. The Q3 results, as bad as they were

Micron Technology: A Reversal Is Imminent: https://www.marketbeat.com/logos/articles/med_20230629090827_copy-1-of-chart-mu-6292023.png
Micron Technology: A Reversal Is Imminent

Micron Technologies (NASDAQ: MU) has been suffering through an inventory correction that has yet to run its course, but a reversal in share prices is imminent. The Q3 results, as bad as they were

Micron Technology: A Reversal Is Imminent: https://www.marketbeat.com/logos/articles/med_20230629090827_copy-1-of-chart-mu-6292023.png
Micron Technology: A Reversal Is Imminent

Micron Technologies (NASDAQ: MU) has been suffering through an inventory correction that has yet to run its course, but a reversal in share prices is imminent. The Q3 results, as bad as they were

McCormick Rebound Imminent: Executive Transition Complete: https://www.marketbeat.com/logos/articles/med_20230629080145_chart-mkc-6292023.png
McCormick Rebound Imminent: Executive Transition Complete

McCormick's (NYSE: MKC) price action wobbled following a better-than-expected Q2 and increased guidance. The news proves that the decision to transition Brenden Foley into the CEO position was

Google Was Just Downgraded, But This Could Be A Good Thing: https://www.marketbeat.com/logos/articles/med_20230629070102_google-was-just-downgraded-but-this-could-be-a-goo.jpg
Google Was Just Downgraded, But This Could Be A Good Thing

After watching their shares rally by more than 50% from last November, it must have been a kick in the teeth for Alphabet Inc (NASDAQ: GOOGL), better known as Google, to receive two downgrades